COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Aéroports de Paris SA - 2024 1st quarter revenue
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: ams-OSRAM AG: delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF (after interest) in 2025
ams-OSRAM AG delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF in 2025 -
COMMUNIQUÉ DE PRESSE
Résultats annuels 2023 : Chiffre d'affaires consolidé 9 mois : 26,0 M EUR (44 M EUR proforma) - Marge d'EBE proforma : 4,4%, supérieur à l'objectif annoncé - Un exercice 2024 de consolidation pour constituer un acteur de référence sur ses marchés
La société Grolleau publie ses résultats annuels 2023 avec un chiffre d'affaires consolidé de 26,0 M€ sur 9 mois et une marge d'EBE proforma de 4,4%. Prévision d'une légère croissance pour 2024 -
COMMUNIQUÉ DE PRESSE
PALFINGER AG: Outstanding results for PALFINGER AG in the first quarter
PALFINGER AG reported outstanding results in Q1 2024 with EUR 578.5 million revenue, record EBIT of EUR 54.7 million and consolidated net result of EUR 32.5 million despite economic challenges. Positive developments in North America, Asia, and the Marine Sector -
-
COMMUNIQUÉ DE PRESSE
Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
Curatis Holding AG announces completion of business combination with Curatis AG, trading on SIX Swiss Exchange under CURN.SW. Specializes in orphan drugs with risk-balanced model -
-
COMMUNIQUÉ DE PRESSE
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted
